pharma · Small Cell Carcinoma of Lung
Shanghai Best-Link Bioscience
Shanghai Best-Link Bioscience is a pharma organization headquartered in CN. Primary therapeutic focus areas include Small Cell Carcinoma of Lung. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 paten
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
BL0020
Phase 2 · small molecule · Small Cell Carcinoma of Lung
BL0020 for Small Cell Carcinoma of Lung is a Phase 2 program (small_molecule) at Shanghai Best-Link Bioscience with 1 ClinicalTrials.gov record(s).
Internal code BL0020-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Shanghai Best-Link Bioscience
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Small Cell Carcinoma of Lung
- Status
- active
- Trials
- 1